GENERAL ANAESTHETIC MODIFICATION OF SYNAPTIC FACILITATION AND LONG-TERM POTENTIATION IN HIPPOCAMPUS M. B. MACIVER, D. L. TAUCK AND J. J. KENDIG
There is increasing evidence that general anaesthetics may act at multiple membrane sites to depress excitatory transmission in central nervous system pathways, and that the combination of actions which results in anaesthesia may differ among agents [1] [2] [3] [4] [5] . This concept represents a significant departure from "unitary" theories of anaesthetic action which propose a common mechanism at a hydrophobic site for all agents [6] [7] [8] . The dissimilar molecular structures exhibited by anaesthetics and the variety of possible sites with which anaesthetics can interact in neuronal membranes provide a high probability that molecular sites of action are different for different agents.
The present study chose two structurally different inhalation agents, a halogenated hydrocarbon (halothane) and a halogenated ether (methoxyflurane) to test this possibility ( fig. 1 ). Rat hippocampal brain slices were chosen as the test preparation because of the ease of controlled extracellular recording of synaptically evoked responses. We examined anaesthetic actions on the CA1 neurone excitatory postsynaptic potential (EPSP) and population spike (PS), with particular attention to the properties of shortterm synaptic facilitation of the EPSP, pairedpulse potentiation of the PS (PP), and long-term PS potentiation (LTP). Synaptic facilitation, PP and LTP are three common manifestations of use-dependent changes in neuronal excitability. As such, they may be of importance in anaesthesia, but have not been studied systematically in this regard. 
SUMMARY

MATERIALS AND METHODS
Preparation
Experiments were conducted on 52 hippocampal slices from male Sprague-Dawley rats (150-250 g). Studies were limited to one or two concentrations of a single anaesthetic in each slice. Rats were anaesthetized with diethyl ether, the heart stopped by a blow to the back of the thorax, and the brain removed rapidly and placed in precooled (10 °C) ) and steric nonconformities of the two anaesthetics. These diagrams were produced using the XICAMM computeraided molecular modelling system (XIRIS Corp., N.J.) and represent low energy conformations of the anaesthetic molecules. C: Diagram of a hippocampal slice showing placement of stimulating (S) and recording electrodes in the somatic (1) and dendritic (2) areas of Ca 1. Recordings of monosynaptically evoked field potentials are shown on the right, D: EPSP produced by low intensity stimuli and recorded at the somatic (1) and dendritic (2) sites, E: Field potentials with population spikes (PS) were produced by higher intensity stimuli. A negative PS is superimposed on the positive EPSP wave form recorded at the somatic site, and a positive PS is superimposed on the negative EPSP at dendritic sites. Note the increase in both EPSP and PS amplitudes following the second of a pair of identical stimuli. CA1-4 = Hippocampal pyramidal neurones; DG = dentate granule neurones; pp = perforant path; mf = mossy fibres; sc = Schaffer collaterals; c/a = commissural/associational fibres; alv = alveus. KC1 4.5; CaCl 2 1.6; KH 2 PO 4 1.25; MgSO 4 2; NaHCO 3 16; dextrose 10. This solution was modified from Richards, Russell and Smaje [9] by adjusting calcium and potassium concentrations to correspond to those measured in vivo [10] .) Following dissection of the dentate-hippocampal formation, transverse slices of hippocampus were cut using a Mcllwain tissue chopper (400 u, Mickel Lab. Eng. Co., U.K.). Slices were maintained on a nylon mesh screen at the gas-liquid interface in a chamber based on the design of Richards and Tegg [11] . Oxygenated (95 % oxygen-5 % carbon dioxide) and prewarmed (35 °C) ACSF was perfused continuously through the chamber at a rate of 0.5-1.0 ml min" 1 .
Electrophysiology
A bipolar tungsten stimulating microelectrode was placed on Schaffer-collateral fibres ( fig. lc) to activate electrically the excitatory synaptic inputs to CA 1 pyramidal neurones. Similarly, antidromic responses were produced by stimulating axons in the alveus. Extracellular glass fibre-fill recording electrodes (filled with ACSF, resistance 0.5-1.0 MO) were placed at the border between stratum pyramidale and stratum oriens (1 in fig. lc ) and in stratum radiatum (2 in fig. lc ) to measure synaptically evoked field potentials at the somatic and dendritic levels, respectively.
Potentiation was denned as the increase in PS amplitude induced by repetitive stimulation. For paired-pulse potentiation experiments (PP), paired stimulus pulses of 0.01-0.05 ms duration (1-12 V) were delivered at 0.08 Hz. Stimulus strength was adjusted to produce half maximal PS on the first pulse.
Facilitation was denned as the increase in EPSP amplitude induced by repetitive stimulation. For facilitation experiments, trains of four stimuli at 20 Hz were applied at intensities subthreshold for PS generation. Interpulse interval was set to 24 ms for PP, and 48 ms for facilitation experiments; these parameters produced optimal facilitation and potentiation in control experiments.
Both PP and facilitation are of brief duration (~ 500 ms), while LTP is the increase (hours to days duration) in PS amplitude induced by a longer stimulus train. Single stimulus trains of 50 Hz for 500 ms were used to induce LTP. Recorded signals were amplified (x 1000), filtered (1 Hz to 10 KHz, bandpass), and stored digitally for later analysis. Records shown are averages of 10 individual field potentials recorded at 0.08 Hz.
EPSP amplitude was chosen in place of rate of rise as a measure of synaptic transmission for two reasons: the use of stimuli subthreshold for PS . generation permitted an independent measure of this parameter, uncomplicated by discharge of CA1 neurones; and in the case of supra-threshold stimulation, the potentiated PS often reduced the rising phase of the EPSP, preventing accurate measurements of rate of rise. EPSP amplitude at the soma was measured as the peak positivity and in the dendritic region as the peak negativity (fig. ID). PS amplitude was measured from threshold to peak negativity (arrowheads in fig. 1E ). Data were standardized as percent of control amplitudes for concentration-response analysis. Control and drug responses were compared using the Wilcoxon two-tailed test.
Administration and analysis of anaesthetics
Halothane and methoxyflurane were applied as vapours via the pre-warmed and humidified oxygen-carbon dioxide gas stream above the slices, using calibrated commercial vaporizers (Foregger, U.S.A., mod. DRV 1; Cyprane, U.K., mod. MKII). Vapour concentrations were applied for a minimum period of 30 min, to ensure that equilibrium was achieved. Steadystate effects on PS amplitudes were observed consistently after 20 min for all concentrations studied. Particular care was taken to examine concentrations relevant to anaesthesia (halothane MAC = 1.2 vol % and methoxyflurane MAC = 0.16 vol%, in rat) [12] .
Accurate measurements of anaesthetic concentrations in the vapour phase were obtained using an infra-red absorption monitor (PuritanBennett Co., U.S.A., mod. AAM222). Sample gas was drawn continuously from the tissue chamber at a site 1.0 mm above the tips of the stimulating electrode placed in the brain slice studied. Chamber concentrations reached equilibrium within 5-10 min of adding the anaesthetic to the gas stream. An approximation of ACSF concentrations of halothane (in mmol litre" 1 ) can be obtained from Maclver and Roth [13] .
Halothane was obtained from Ayerst Laboratories Inc., U.S.A., and methoxyflurane from Abbott Laboratories, U.S.A. All chemicals were reagent grade or better and were obtained from J. T. Baker Chemical Co., U.S.A.; water for solutions was "tissue culture" grade obtained from Dr J. R. Trudell (Stanford University Medical Center).
RESULTS
Anaesthetic-induced depression of evoked discharge
Methoxyflurane and halothane produced a marked depression of the synaptically evoked population spike recorded from CA1 pyramidal neurones ( fig. 2) . Concentrations which correspond to 1 MAC for each agent reduced CA1 evoked discharge to 2.7 (SD 3.1)% and 1.0 (6.3)% of control for methoxyflurane 0.16 vol% and halothane 1.2 vol%, respectively. Halothane was consistently more effective at blocking PS responses to a single stimulus (ED 50 = 0.25 vol %) than the facilitated PS response to the second of a pair of stimuli (ED 50 = 0.54 vol %) ( fig. 2B ). Methoxyflurane produced greater depression of the facilitated than the single PS response in some experiments (five of 18; e.g. fig. 2A ); however, in most experiments the response to a single stimulus was more sensitive to this agent also. Concentration-response graphs for depression of PS responses to a pair of stimuli of equal strength are shown on the right of figure 2. The mean (SD) difference in sensitivity between the first and second response across the effective concentration range was 28.3 (3.64)% for halothane and 19.9 (8.4)% for methoxyflurane.
Comparison of effects on EPSP v. PS discharge
Effects on evoked dendritic and somatic field potential responses were compared, to determine if the anaesthetic-induced depression of PS responses was a result of block of excitatory transmission at the synapse or of depression of spike initiation in the postsynaptic neurones. The dendritic field potential is composed predomi- nantly of the EPSP, while the potential recorded at the soma reflects the population spike [14] . As shown in figure 3 , both agents produced a greater reduction in field potential amplitudes recorded at the somatic than at the dendritic level. In this experiment, halothane 1.2vol% produced a marked reduction in PS amplitude (>90%) with only a slight depression (<10%) of field EPSP responses recorded at the dendritic site. Methoxyflurane 0.16 vol% produced a more pronounced depression of field EPSP responses (> 15%), but the major effect of this agent also appeared to involve a depression of postsynaptic excitability (PS responses reduced to < 30 % of control). For halothane, the depression of discharge was accompanied by an increase in threshold, measured as the point of PS initial inflection on the EPSP (fig. 3B ). This was not the case for methoxyflurane, which decreased PS threshold ( fig. 3A) . In the presence of 1 MAC of either anaesthetic, the depression of synaptically evoked PS potentials was attributed to a reduction in the number of CA1 neurones discharging, or to a smaller discharge current produced in each cell. In this regard, it is interesting that neither halothane nor methoxyflurane altered PS responses to antidromic stimuli at 1 MAC.
Effects on facilitation of field EPSP responses
Examination of the dendritic field EPSP responses in the presence of the anaesthetics suggested that facilitation of synaptic transmission may have been increased by both halothane and methoxyflurane ( fig. 3) . EPSP responses to a short train of stimuli (four pulses at 20 Hz) were studied to determine if facilitation was increased by these agents. In the presence of 1 MAC of either anaesthetic, EPSP facilitation was increased ( fig. 4) . Halothane increased facilitation by 44% and methoxyflurane increased it by 15%. The increase in facilitation was sufficient to overcome the anaesthetic-induced depression of EPSP responses with 1 MAC of halothane; however, PS responses never approached control levels, even at high frequencies of stimulation (e.g. fig. 6 ). The increase in EPSP facilitation could account for the difference in anaesthetic potency between the first and second PS responses described above ( fig. 2,  fig. 3A , B). Figure 5 illustrates the experimental procedure used to study anaesthetic effects on long-term potentiation (LTP) of synaptic responses. When a stable (< 5 % variability/30 min) control response was obtained, the anaesthetic was applied for at least 20 min to achieve steady-state effects on PS amplitudes. An LTP-inducing stimulus train (50 Hz, 500 ms) was applied while the anaesthetic was still present and responses were monitored for an additional 20 min. During this time, potentiation was often observed as an increase in the anaesthetic-depressed field potential amplitude ; a further increase occurred following washout of the anaesthetic (dashed line in figure 5 ). LTP was considered to have been evoked if PS amplitudes remained greater than 110% of preanaesthetic control for at least 1 h after washout.
Effects on long-term potentiation
Even high concentrations (e.g. 0.2vol%) of methoxyflurane did not alter significantly the probability of producing LTP (16 of 18 experiments; probability = 0.89; P > 0.05) compared with control experiments (14 of 16 experiments; probability = 0.88). In contrast, halothane reduced significantly the probability of producing LTP (probability = 0.5 at 1.2vol%; « = 6; P<0.01). The effect of halothane on probability of LTP induction is shown at the top right of figure 6. All concentrations greater than 0.25 vol % produced comparable depression of LTP induction.
The depression of LTP produced by halothane was correlated with the presence of PS response during the LTP-inducing stimulus train. As shown on the left side of figure 6, in control conditions the stimulus train elicits population spikes in response to each pulse during the train. In the presence of either anaesthetic, PS responses were nearly abolished after the first few pulses of the stimulus train. Halothane may depress LTP induction by blocking postsynaptic discharge since, in the presence of this agent, the probability of LTP was correlated with the presence of PS responses during the inducing train (r = 0.92; lower right of figure 6 ). Figure 6 illustrates the marked difference between methoxyflurane and halothane with respect to LTP induction. LTP was produced in the presence of 0.2 vol % methoxyflurane, but not in the presence of 0.5 vol % halothane, even though methoxyflurane produced a greater depression of discharge during the LTP-inducing train.
DISCUSSION
Anaesthetic-induced depression of synoptic transmission
Both anaesthetics in the present study produced a marked depression of CNS synaptic transmission as measured by PS amplitude (fig. 7 ).
Concentrations equivalent to 1 MAC for both agents significantly blocked synaptically evoked discharge of the hippocampal CA1 population in response either to a single stimulus or to a paired stimulus which evoked a potentiated response (dashed line in figure 7) . These results support previous observations that hippocampal cortical neurones are sensitive to both volatile and barbiturate general anaesthetics at clinically relevant concentrations [2, [13] [14] [15] [16] , as are neurones in olfactory cortical slices [10, 17] . The sensitivity of both tissues lends support to the proposal that cortical excitatory transmission is depressed during anaesthesia [18] .
Differential effects of anaesthetics on evoked responses
Although both anaesthetics produced a depression of the singly evoked PS, the mech- anisms underlying this effect appeared to differ between the agents. Halothane depressed postsynaptic spike discharge by a predominantly non-synaptic action indicated by the marked depression of PS amplitudes with little effect on EPSP responses ( fig. 3 ) [see also : 13,19,20] . This postsynaptic depressant action of halothane resembles, to some degree, the effects produced by barbiturates on this synaptic pathway [16] , particularly with respect to the apparent increase in discharge threshold (arrowheads in fig. 3B ). In contrast, methoxyflurane depressed EPSP responses, which contributed to the observed reduction of PS amplitudes. In this regard, methoxyflurane resembles closely the related halogenated ether anaesthetics, isoflurane and enflurane, which also depress EPSP responses at concentrations which reduce PS amplitudes [13] . Methoxyflurane also resembles enflurane in reducing the threshold for PS generation (figs 2, 3); but, unlike the effect of enflurane, the reduction in discharge threshold was not sufficient to produce spontaneous or evoked burst firing of the CA1 population [15] . The differential effects produced by methoxyflurane and halothane, summarized in table I, provide further support for discrete anaesthetic-specific interactions with membrane recognition sites [21] .
Effects on EPSP facilitation and paired-pulse potentiation
Halothane produced a greater depression of PS responses to the first compared with the second of a pair of stimuli ( fig. 2) . The difference in sensitivity between the two responses could be accounted for by the observed increase in EPSP facilitation produced by halothane (figs 3, 4). Anaesthetic-induced increases in facilitation are observed also at the crustacean neuromuscular junction [22] , in which facilitation is presumed to be a property of the presynaptic nerve terminal. Halothane effects on PS responses to a pair of stimuli may be explained by postulating that halothane increases both EPSP facilitation and the threshold for spike initiation [20] . On the other hand, methoxyflurane also increased EPSP facilitation but reduced PS potentiation in 28 % of experiments (e.g. fig. 2 ). These apparently contradictory findings might be explained if methoxyflurane, in common with barbiturates [16, 23] , significantly increased intrinsic or synaptic inhibitory currents which limit the ability of neurones to generate repetitive impulses [24, 25] . Evidence suggestive that halothane and methoxyflurane differ in this respect is provided by the observation that the two agents induce opposite shifts in the baseline during high frequency stimulus trains ( fig. 6 ).
Effects on long-term potentiation
The two anaesthetics had markedly different effects on LTP induction. Halothane produced a reduction in the probability of occurrence of LTP which correlated well with the anaestheticinduced depression of PS responses during the stimulus train ( fig. 6 ), while methoxyflurane did not block LTP. Both calcium entry and depolarization are normally required for the expression of LTP [26, 27] . Halothane-induced block of LTP may be attributed to reduced postsynaptic depolarization; however, methoxyflurane acts at pre-or postsynaptic sites, or both, to preserve LTP induction despite a comparable depression of discharge. The i.v. anaesthetics ketamine and phencyclidine also block LTP, but by a different mechanism which involves inhibition of the NMDA receptor-calcium ionophore [28, 29] .
Membrane actions of anaesthetics
The differential actions produced by halothane and methoxyflurane (table I) are not compatible with a common effect at identical membrane sites, as required by unitary theories of anaesthetic action [7, 8] . Because these agents exhibit different molecular properties such as size, volume and charge distribution ( fig. 1) , they bind to different membrane microdomains composed of heterogeneously distributed proteins (e.g. neurotransmitter receptors and ion channels) [30] and associated lipids [31] [32] [33] . Results of the present study demonstrate agent-specific actions at sites which discriminate between the molecular structures of inhalation anaesthetics.
